ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Amir Kramer
Jacob Gurevitch
Rephael Mohr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lev-Ran, O.
Right arrow Articles by Mohr, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lev-Ran, O.
Right arrow Articles by Mohr, R.

Ann Thorac Surg 2000;69:264-265
© 2000 The Society of Thoracic Surgeons


Case Reports

Low-molecular-weight heparin for prosthetic heart valves: treatment failure

Oren Lev-Ran, MDa, Amir Kramer, MDa, Jacob Gurevitch, MDa, Itzhak Shapira, MDa, Rephael Mohr, MDa

a Department of Thoracic and Cardiovascular Surgery, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel

Address reprint requests to Dr Mohr, Department of Thoracic and Cardiovascular Surgery, Tel-Aviv Sourasky Medical Center, 6 Weizman St, Tel-Aviv 64239, Israel

There is no adequate substitute therapy for patients with prosthetic heart valves, in whom anticoagulation with warfarin or unfractionated heparin must be withheld. In the literature there are several reports describing successful treatment with low-molecular-weight heparin in patients with prosthetic heart valves. We report two cases of low-molecular-weight heparin treatment failure resulting in thrombosed prosthetic heart valves with stormy clinical presentations, who underwent successful valve replacements.




This article has been cited by other articles:


Home page
HeartHome page
A. Shlebak and I. Malik
Managing heparin anticoagulation in patients with prosthetic cardiac valves: balancing the risk
Heart, October 15, 2009; 95(20): 1643 - 1645.
[Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
A. Gerhardt, R. E. Scharf, and R. B. Zotz
Successful Use of Danaparoid in Two Pregnant Women With Heart Valve Prosthesis and Heparin-Induced Thrombocytopenia Type II (HIT)
Clinical and Applied Thrombosis/Hemostasis, August 1, 2009; 15(4): 461 - 464.
[Abstract] [PDF]


Home page
ChestHome page
S. M. Bates, I. A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 844S - 886S.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. P. Karjalainen, S. Vikman, M. Niemela, P. Porela, A. Ylitalo, M.-A. Vaittinen, M. Puurunen, T. J. Airaksinen, K. Nyman, T. Vahlberg, et al.
Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment
Eur. Heart J., April 2, 2008; 29(8): 1001 - 1010.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
A. C. Spyropoulos
Outpatient-Based Primary and Secondary Thromboprophylaxis With Low-Molecular-Weight Heparin
Clinical and Applied Thrombosis/Hemostasis, January 1, 2008; 14(1): 63 - 74.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
U. Elkayam and F. Bitar
Valvular Heart Disease and Pregnancy: Part II: Prosthetic Valves
J. Am. Coll. Cardiol., August 2, 2005; 46(3): 403 - 410.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. A. Greer and C. Nelson-Piercy
Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy
Blood, July 15, 2005; 106(2): 401 - 407.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. M. Bates, I. A. Greer, J. Hirsh, and J. S. Ginsberg
Use of Antithrombotic Agents During Pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 627S - 644S.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
U. Elkayam, H. Singh, A. Irani, and M. W. Akhter
Anticoagulation in Pregnant Women With Prosthetic Heart Valves
Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 107 - 115.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
J. E. Ansell
The Perioperative Management of Warfarin Therapy
Arch Intern Med, April 28, 2003; 163(8): 881 - 883.
[Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
C. JOHNSON-LEONG and R. E. RADA
The use of low-molecular-weight heparins in outpatient oral surgery for patients receiving anticoagulation therapy
J Am Dent Assoc, August 1, 2002; 133(8): 1083 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. G. Leyh, S. Fischer, A. Ruhparwar, and A. Haverich
Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative?
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 577 - 579.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Dahm, G. Hafner, H. Schinzel, E. Mayer, D. Prufer, and H. Oelert
Early antithrombotic management after valve replacement
Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q12 - Q15.
[Abstract] [PDF]


Home page
HeartHome page
G. HANANIA
Management of anticoagulants during pregnancy
Heart, August 1, 2001; 86(2): 125 - 126.
[Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. S Kabbani
Is it Time to Look for an Alternative?
Asian Cardiovasc Thorac Ann, June 1, 2001; 9(2): 79 - 81.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.